Amid the concerns surrounding potential rare side effects of the AstraZeneca-Oxford Covid-19 vaccine, the pharmaceutical ...

Cambridge [United Kingdom], May 1 (ANI): In light of recent concerns surrounding potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical giant has reiterated its ...

European safety regulators have launched an investigation into the safety of a batch of the Oxford University/AstraZeneca COVID-19 vaccine, as countries including Denmark suspended its use as a ...

Patient safety is our highest priority." The statement added that AstraZeneca’s vaccine “has continuously been shown to have an acceptable safety profile and regulators around the world ...

Following the announcement on the withdrawal of the AstraZeneca vaccine from the global market, there have been muted grumbling over its safety, with a huge number of Kenyans having received it at ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

The COVID-19 pandemic has prompted the rapid development and administration of various vaccines worldwide, with some reports linking these vaccines to immune thrombotic thrombocytopenic purpura (TTP).

With a new hearing scheduled for November 27, 2024, questions persist regarding the safety of the vaccine ... several vaccines including AstraZeneca, Moderna, Pfizer-BioNTtech, Johnson and Johnson ...

Last week, AstraZeneca reiterated its commitment to patient safety while emphasising the vaccine's overall safety profile. An AstraZeneca spokesperson had stated, "Our sympathy goes out to anyone ...

AstraZeneca has paused its planned £450 million investment in the UK for vaccine R&D as it continues discussions with the ...

“At the current time, the use of the Pfizer vaccine is preferred over the AstraZeneca vaccine in adults aged less than 50 years who have not already received a first dose of AstraZeneca vaccin ...